Krill oil
Dietary SupplementKrill oil 300 mg DHA/EPA daily for 6 weeks
NCT Number: NCT01705678
There is some evidence that dietary supplementation with fish oil has health benefits, especially in respect of some of the known risk factors for cardiovascular (heart) disease such as cardiac arrhythmia. However, supplies of fish oil are limited, and it is desirable to validate alternative sustainable sources of the important omega-3 fatty acid components. It has been suggested that oil from krill, which are small marine crustaceans, may be as effective or possibly more beneficial than fish oil, and may provide a more effective and beneficial supplement. Dietary management of cardiovascular health parameters (such as blood lipids)is becoming more and more important as the rising trends in obesity nationally and worldwide are leading to escalating incidence of diabetes and heart disease. The investigators propose to use some specific novel lipid measurements of cardiovascular risk to test this possibility in a group of men who, although generally healthy, show some risk factors in terms of their weight and metabolic profile.This pilot study will provide preliminary data to show whether krill oil has similar or different effects from fish oil on the cardiovascular health of overweight but otherwise healthy men, and in particular will provide detailed information on alterations in novel lipid markers of cardiovascular disease, which may be a better diagnostic tool than classical lipid measurements (e.g. serum cholesterol). The investigators have been developing and validating new techniques to measure emerging lipid markers of cardiovascular risk accurately and will continue to develop and investigate these techniques during the course of this project. The investigators hypothesise that krill oil will be more efficacious in reducing markers of risk relating to cardiovascular disease.
Looking for future studies?
Notify Me35 year–65 year
Male
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Plus any two of the below:
Exclusion criteria
Krill oil 300 mg DHA/EPA daily for 6 weeks
Fish oil 500 mg DHA/EPA daily for 6 weeks
Time frame: Change from baseline at 3 weeks
Change in plasma triglycerides from baseline to midpoint
Time frame: Change from baseline at 3 weeks
Change in plasma High density lipoprotein cholesterol from baseline to midpoint
Time frame: Change from baseline at 3 weeks
Change in plasma glucose from baseline to midpoint
Time frame: Change from baseline at 6 weeks
Change in waist circumference from baseline to endpoint
Time frame: Change from baseline at 6 weeks
Change in systolic blood pressure from baseline to endpoint
Time frame: Change from baseline at 6 weeks
Change in diastolic blood pressure from baseline to endpoint
Time frame: Change from baseline at 6 weeks
Change in plasma triglycerides at baseline to endpoint
Time frame: Change from baseline at 6 weeks
Change in plasma glucose from baseline to endpoint
Time frame: Change from baseline at 6 weeks
Change in high density lipoprotein cholesterol from baseline to endpoint
Time frame: Change from baseline at 6 weeks
Change in body mass measured at baseline to endpoint
Time frame: Change from baseline at 3 weeks
Change in plasma cholesterol from baseline to midpoint
Time frame: Change from baseline at 6 weeks
Change in body mass index at baseline to endpoint
Time frame: Change from baseline at 6 weeks
Change in plasma cholesterol from baseline to endpoint
Time frame: Change from baseline at 3 weeks
Change in plasma insulin from baseline to midpoint
Time frame: Change from baseline at 6 weeks
Change in plasma insulin from baseline to endpoint
Time frame: Change from baseline at 6 weeks
Change in small, dense low density lipoprotein cholesterol from baseline to endpoint
Time frame: Change from baseline at 3 weeks
Change in plasma low density lipoprotein cholesterol from baseline to midpoint
Time frame: Change from baseline at 6 weeks
Change in plasma low density lipoprotein cholesterol from baseline to endpoint
Liverpool John Moores University
Other
An Investigation Into the Effects of Krill Oil vs. Fish Oil on Markers of Cardiovascular Disease in Males With Metabolic Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956886
Dyssomnias, Glucose Metabolism Disorders
Newark, Delaware, United States
View Trial DetailsNCT07739602
Glucose Metabolism Disorders, Hyperinsulinism
Wroclaw, Poland
View Trial DetailsNCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial Details